StocksFundsScreenerSectorsWatchlists
TLRY

TLRY - Tilray Inc Stock Price, Fair Value and News

1.73USD+0.01 (+0.58%)Market Closed

Market Summary

TLRY
USD1.73+0.01
Market Closed
0.58%

TLRY Alerts

  • Big jump in Revenue (Y/Y)
  • Big jump in Earnings (Y/Y)
  • Losses in recent quarter

TLRY Stock Price

View Fullscreen

TLRY RSI Chart

TLRY Valuation

Market Cap

1.3B

Price/Earnings (Trailing)

-3.8

Price/Sales (Trailing)

1.8

EV/EBITDA

-4.15

Price/Free Cashflow

-74.33

TLRY Price/Sales (Trailing)

TLRY Profitability

Operating Margin

86.69%

EBT Margin

-42.75%

Return on Equity

-10.53%

Return on Assets

-8.35%

Free Cashflow Yield

-1.35%

TLRY Fundamentals

TLRY Revenue

Revenue (TTM)

743.2M

Rev. Growth (Yr)

29.36%

Rev. Growth (Qtr)

-2.8%

TLRY Earnings

Earnings (TTM)

-351.9M

Earnings Growth (Yr)

92.08%

Earnings Growth (Qtr)

-89.15%

Breaking Down TLRY Revenue

Last 7 days

-4.9%

Last 30 days

-12.6%

Last 90 days

-13.5%

Trailing 12 Months

-26.4%

How does TLRY drawdown profile look like?

TLRY Financial Health

Current Ratio

1.92

Debt/Equity

0.04

Debt/Cashflow

-0.14

TLRY Investor Care

Shares Dilution (1Y)

25.25%

Diluted EPS (TTM)

-0.47

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
2024743.2M000
2023596.3M627.1M650.9M700.5M
2022617.3M628.4M613.6M602.5M
2021361.3M370.7M482.2M513.4M
2020295.7M320.3M333.5M348.8M
201958.4M179.3M293.7M281.1M
201823.3M28.1M32.7M43.1M
201714.6M16.6M18.6M20.5M
201600012.6M

Tracking the Latest Insider Buys and Sells of Tilray Inc

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
Jan 17, 2024
faltischek denise m
bought
20,500
2.05
10,000
chief strategy officer
Jan 16, 2024
gendel mitchell
bought
14,256
1.98
7,200
global general counsel
Jan 12, 2024
gendel mitchell
bought
10,098
1.87
5,400
global general counsel
Jan 12, 2024
merton carl a
bought
37,400
1.87
20,000
chief financial officer
Jan 12, 2024
simon irwin d
bought
100,956
1.88
53,700
president and ceo
Jul 31, 2023
merton carl a
acquired
475,266
2.53
187,852
chief financial officer
Jul 31, 2023
faltischek denise m
sold (taxes)
-242,624
2.53
-95,899
chief strategy officer
Jul 31, 2023
simon irwin d
sold (taxes)
-1,976,170
2.53
-781,094
president and ceo
Jul 31, 2023
faltischek denise m
acquired
475,266
2.53
187,852
chief strategy officer
Jul 31, 2023
merton carl a
sold (taxes)
-238,394
2.53
-94,227
chief financial officer

1–10 of 50

Which funds bought or sold TLRY recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
Apr 18, 2024
WOLFF WIESE MAGANA LLC
unchanged
-
28.00
413
-%
Apr 18, 2024
SeaCrest Wealth Management, LLC
reduced
-12.05
-1,339
27,047
-%
Apr 18, 2024
Roberts Wealth Advisors, LLC
unchanged
-
-174,700
79,300
0.03%
Apr 18, 2024
SJS Investment Consulting Inc.
sold off
-100
-3,496
-
-%
Apr 18, 2024
Piscataqua Savings Bank
unchanged
-
38.00
518
-%
Apr 18, 2024
McGlone Suttner Wealth Management, Inc.
sold off
-100
-460
-
-%
Apr 18, 2024
AlphaMark Advisors, LLC
reduced
-7.86
-
13,000
-%
Apr 18, 2024
Aspire Private Capital, LLC
unchanged
-
13.00
180
-%
Apr 17, 2024
BARRETT & COMPANY, INC.
new
-
25,935
25,935
0.01%
Apr 17, 2024
Cedar Brook Financial Partners, LLC
new
-
31,823
31,823
0.01%

1–10 of 48

Are Funds Buying or Selling TLRY?

Are funds buying TLRY calls or puts?
Calls
Puts
No. of funds holding Calls - Puts
Net Call Options
No. of funds that own TLRY
No. of Funds

Unveiling Tilray Inc's Major ShareHolders

Date FiledName of FilerPercent of ClassNo. of SharesForm Type
Feb 13, 2023
hudson bay capital management lp
2.23%
14,006,029
SC 13G/A
Feb 10, 2023
hudson bay capital management lp
9.99%
68,275,295
SC 13G
May 25, 2021
kennedy brendan
2.9%
12,837,819
SC 13D/A
Feb 16, 2021
cvi investments, inc.
-
7,012,907
SC 13G/A
Feb 16, 2021
etf managers group, llc
4.08%
5,446,196
SC 13G/A
Feb 16, 2021
groh christian
229%
3,930,804
SC 13D/A
Feb 16, 2021
blue michael g.
906%
4,598,454
SC 13D/A
Feb 16, 2021
kennedy brendan
7.9%
12,782,843
SC 13D/A
Dec 07, 2020
etf managers group, llc
5.01%
6,690,462
SC 13G/A
Nov 16, 2020
etf managers group, llc
4.71%
6,282,498
SC 13G/A

Recent SEC filings of Tilray Inc

View All Filings
Date Filed Form Type Document
Apr 09, 2024
8-K
Current Report
Apr 09, 2024
10-Q
Quarterly Report
Feb 16, 2024
8-K
Current Report
Feb 16, 2024
424B7
Prospectus Filed
Feb 06, 2024
8-K
Current Report
Jan 19, 2024
4
Insider Trading
Jan 18, 2024
4
Insider Trading
Jan 16, 2024
4
Insider Trading
Jan 12, 2024
4
Insider Trading
Jan 12, 2024
4
Insider Trading

Peers (Alternatives to Tilray Inc)

NameMkt Capsorted ascendingRevenuePrice %, 1MReturns, 1YP/EP/SRev 1-YrInc 1-Yr
LARGE-CAP
356.3B
85.2B
-5.03% -9.57%
10.14
4.18
6.46% 95.94%
318.7B
60.1B
1.61% 10.23%
873.24
5.3
1.40% -97.49%
146.8B
46.5B
-6.17% -34.78%
-105.7
3.15
42.59% -114.62%
144.1B
28.2B
-1.51% 10.46%
21.46
5.11
7.09% 2.52%
83.2B
27.1B
-9.77% -21.18%
14.68
3.07
-0.60% 23.36%
14.4B
15.8B
-4.60% 54.01%
-25
0.91
6.17% 76.47%
MID-CAP
4.2B
4.7B
-1.63% -14.16%
-328.55
0.9
4.58% 90.97%
4.0B
1.7B
-13.93% -17.76%
11.2
2.4
49.61% 324.78%
3.2B
8.8B
-9.38% 13.00%
-5.36
0.36
7.79% -163.11%
1.9B
644.4M
-9.13% -7.04%
13.99
2.99
29.14% 50.51%
SMALL-CAP
1.3B
743.2M
-12.63% -26.38%
-3.8
1.8
24.65% 80.36%
21.6M
1.3M
-20.43% -49.32%
-2.1
16.56
-98.14% -109.18%
16.6M
-
-10.09% 36.11%
-0.9
0.22
2882.68% -138.52%
2.6M
19.6M
-34.48% -94.22%
-0.18
0.13
80.00% 43.08%
472.0K
117.6M
-96.45% -95.94%
0
0
-0.79% -283.60%

Tilray Inc News

Latest updates
MarketBeat41 hours ago
The Globe and Mail17 Apr 202409:02 pm
MarketWatch15 Apr 202409:35 pm
Investor's Business Daily12 Apr 202402:08 pm
Seeking Alpha07 Apr 202407:00 am

Tilray Inc Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)
Income Statement (Quarterly)
(In Thousands)
(*) denotes actual numbers (not divided by Thousands)
Description(%) Q/Q2024Q12023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12021Q12020Q42020Q42020Q32020Q32020Q22020Q22020Q1
Revenue-2.8%188,340,000193,771,000176,949,000184,188,000145,589,000144,136,000153,211,000153,325,000151,871,000155,153,000168,023,000142,236,00048,021,000123,900,00056,560,000129,459,00051,406,000117,490,00050,414,000113,542,00052,102,000
Gross Profit4.2%49,396,00047,409,00044,196,00067,163,000-11,699,00042,882,00048,614,000-6,733,00039,829,00032,766,00050,955,00022,498,00013,503,00030,456,00016,642,00035,283,0003,330,00034,945,000-5,824,00027,807,00010,870,000
Costs and Expenses-100.0%-16,451,00015,887,000-2,469,000164,498,00015,835,00072,934,00025,870,00013,509,000936,00026,067,000----------
Operating Expenses47.5%131,494,00089,168,00078,558,000157,143,0001,195,037,00094,673,00069,792,000460,690,00057,909,00088,295,000120,324,00096,185,000-54,506,000-61,243,000-43,419,000---
  S&GA Expenses31.8%9,995,0007,583,0006,859,0009,048,0006,452,0009,669,0009,671,0009,643,0008,641,0009,210,0007,432,000-9,739,0006,155,00034,861,5006,079,00010,000,0005,817,00012,833,000-18,326,000
  R&D Expenses89.3%106,00056,00079,000180,000171,000165,000166,00054,000164,000515,000785,000-1,202,000127,0003,545,500225,000921,000120,000652,000-1,347,000
EBITDA Margin78.9%-0.43-2.02-2.02-2.11-2.81-0.69-0.56-0.49-0.47-0.57-0.61-0.79---------
Income Taxes-184.9%-2,871,0003,380,0007,264,000-3,581,000-10,811,00011,713,0007,211,000-3,803,000-1,830,000-5,671,0004,762,000-378,0006,310,00022,582,000-14,192,000243,000-5,825,000-39,000-301,000
Earnings Before Taxes-117.6%-107,854,000-49,563,000-48,599,000-111,687,000-1,206,563,000-73,348,000-58,583,000-461,603,00050,645,000126,000-29,842,000--341,212,000-252,333,000-130,911,000-103,441,000-1,939,000-27,569,000-84,601,000--185,094,000
EBT Margin78.9%-0.43-2.02-2.21-2.31-3.02-0.90-0.77-0.70-0.56-0.67-0.72-0.93---------
Net Income-89.2%-92,701,000-49,008,000-71,525,000-138,713,000-1,170,998,000-69,463,000-73,482,000-478,141,00043,190,000-201,000-41,649,00047,204,000-340,955,000-273,519,000-2,947,000-99,900,000-2,316,000-34,343,000-81,687,000-87,105,000-184,123,000
Net Income Margin76.8%-0.47-2.04-2.23-2.32-3.01-0.96-0.83-0.760.08-0.72-0.76-0.99---------
Free Cashflow49.5%-15,361,000-30,409,000-18,308,00041,132,000-21,098,00026,743,000-48,735,000-22,990,000-48,856,000-19,587,000-95,693,000-15,474,000---------
Balance Sheet
(In Millions)
Balance Sheet
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2024Q12023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q22020Q12019Q42019Q3
Assets-2.7%4,2134,3314,4024,3074,3765,4745,5925,4505,4505,8195,7635,9866,0251,1689468878561,7389168961,040
  Current Assets-1.7%631642829773759815911804804696708845884572347305290582339259331
    Cash Equivalents2.0%14614317820716519049141641627933237648841619015513736117497.00100
  Inventory-3.4%24425323220120324124524624627323325225697.0094.0090.0093.0014096.0088.00110
  Net PPE-579--430---587----651198200188176-187184166
  Goodwill0.0%2,0102,0102,0102,0092,0062,6212,6182,6412,6412,8353.002,8092,833169167160156447160163163
Liabilities-7.2%8709371,0019779699911,0291,0081,0081,1581,2901,6011,560628572701724463725611624
  Current Liabilities-16.7%32939553743347042727328028028231552740128418113416412017192.00130
  Short Term Borrowings-25.5%15.0020.0015.0023.0018.0015.0018.0018.0018.0017.009.009.009.00----0.00---
  Long Term Debt2.3%127124121221223223-402402121152165167----94.00---
    LT Debt, Current-35.1%83.0012825217418418264.00--70.0032.0031.0037.00----6.00---
    LT Debt, Non Current-100.0%-124121221223223-402402121152165167----94.00---
Shareholder's Equity-0.8%3,3433,3683,4023,3163,4044,4834,5634,4414,3994,6614,4734,3864,4655413741871311,275190285416
  Retained Earnings-3.7%-2,628-2,536-2,487-2,415-2,276-1,105-1,036-962-962-484-527-527-486-1,071-730-727-724-113-643-430-209
  Additional Paid-In Capital1.5%6,0315,9435,9105,7785,7235,6975,6415,3825,3825,1114,9554,7964,7921,6001,0969118561,367840706623
Shares Outstanding5.6%774733723657618612575533533486455449270--------
Minority Interest-163.2%-15.8225.0022.0014.003.0013.0038.0043.0043.0034.0037.0066.006.00----27.00---
Float------2,400----5.00-676---676----
Cashflow (Last 12 Months)
(In Thousands)
Cashflow (Quarterly)
(In Thousands)
(*) denotes actual numbers (not divided by Thousands)
Description(%) Q/Q2024Q12023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12021Q12020Q42020Q42020Q32020Q32020Q22020Q22020Q1
Cashflow From Operations49.5%-15,361-30,409-15,84243,598-18,63229,209-46,269-20,524-46,390-17,121-93,227--13,008--19,589---56,100---54,031
  Share Based Compensation-1.7%8,0598,2018,2579,8299,63010,9439,1938,9699,35513,5964,074-7,193-18,5272598,0802,8507,647-7,677
Cashflow From Investing-65.5%28,08681,497-26,290-7,584-4,592-271,398-1,537-4,915-1,026-6,972-8,620--69.00-266,588---13,698---18,119
Cashflow From Financing87.2%-10,909-85,36614,0186,236-2,442-57,256123,620161,808-5,565-20,019-8,028-234,081-152,172--6,737--159,786

TLRY Income Statement

2024-02-29
Consolidated Statements of Loss and Comprehensive Loss (Unaudited) - USD ($)
$ in Thousands
3 Months Ended9 Months Ended
Feb. 29, 2024
Feb. 28, 2023
Feb. 29, 2024
Feb. 28, 2023
Net revenue$ 188,340$ 145,589$ 559,060$ 442,936
Cost of goods sold138,944157,288418,059363,139
Gross profit (loss)49,396(11,699)141,00179,797
Operating expenses:    
General and administrative39,94038,999123,769117,385
Selling9,9956,45224,43725,792
Amortization21,55823,51865,70071,872
Marketing and promotion11,1917,35428,93423,137
Research and development106171241502
Change in fair value of contingent consideration(5,983)352(16,790)563
Impairments0934,0000934,000
Other than temporary change in fair value of convertible notes receivable42,681181,37642,681181,376
Litigation costs, net of recoveries3,363(5,230)8,439(1,970)
Restructuring costs5,1782,6638,74810,727
Transaction costs (income)3,4655,38213,061(3,882)
Total operating expenses131,4941,195,037299,2201,359,502
Operating loss(82,098)(1,206,736)(158,219)(1,279,705)
Interest expense, net(8,517)(1,040)(26,977)(8,560)
Non-operating income (expense), net(17,239)1,213(20,820)(50,229)
Loss before income taxes(107,854)(1,206,563)(206,016)(1,338,494)
Income tax (recovery) expense(2,871)(10,811)1,013(15,313)
Net loss(104,983)(1,195,752)(207,029)(1,323,181)
Total net income (loss) attributable to:    
Stockholders of Tilray Brands, Inc.(92,701)(1,170,998)(213,234)(1,313,943)
Non-controlling interests(12,282)(24,754)6,205(9,238)
Other comprehensive gain (loss), net of tax    
Foreign currency translation gain (loss)(4,696)6,3903,716(78,499)
Unrealized gain (loss) on convertible notes receivable095,345075,177
Total other comprehensive gain (loss), net of tax(4,696)101,7353,716(3,322)
Comprehensive loss(109,679)(1,094,017)(203,313)(1,326,503)
Total comprehensive income (loss) attributable to:    
Stockholders of Tilray Brands, Inc.(97,521)(1,092,491)(209,811)(1,336,127)
Non-controlling interests$ (12,158)$ (1,526)$ 6,498$ 9,624
Weighted average number of common shares - basic (in shares)754,439,331615,534,670725,346,952597,829,714
Weighted average number of common shares - diluted (in shares)754,439,331615,534,670725,346,952597,829,714
Net loss per share - basic (in dollars per share)$ (0.12)$ (1.9)$ (0.29)$ (2.2)
Net loss per share - diluted (in dollars per share)$ (0.12)$ (1.9)$ (0.29)$ (2.2)

TLRY Balance Sheet

2024-02-29
Consolidated Statements of Financial Position (Current Period Unaudited) - USD ($)
$ in Thousands
Feb. 29, 2024
May 31, 2023
Current assets  
Cash and cash equivalents$ 146,253$ 206,632
Marketable securities79,605241,897
Accounts receivable, net89,54286,227
Inventory244,139200,551
Prepaids and other current assets43,03437,722
Assets held for sale28,6380
Total current assets631,211773,029
Capital assets578,783429,667
Operating lease, right-of-use assets17,4535,941
Intangible assets930,105973,785
Goodwill2,009,6322,008,843
Interest in equity investees04,576
Long-term investments8,0587,795
Convertible notes receivable32,000103,401
Other assets5,614222
Total assets4,212,8564,307,259
Current liabilities  
Bank indebtedness15,02923,381
Accounts payable and accrued liabilities209,763190,682
Contingent consideration016,218
Warrant liability3,1821,817
Current portion of lease liabilities5,4242,423
Current portion of long-term debt12,35124,080
Current portion of convertible debentures payable83,351174,378
Total current liabilities329,100432,979
Long - term liabilities  
Contingent consideration14,00010,889
Lease liabilities73,2287,936
Long-term debt165,648136,889
Convertible debentures payable126,587221,044
Deferred tax liabilities, net161,042167,364
Other liabilities210215
Total liabilities869,815977,316
Commitments and contingencies (refer to Note 19)
Stockholders' equity  
Common stock ($0.0001 par value; 1,198,000,000 common shares authorized; 774,028,053 and 656,655,455 common shares issued and outstanding, respectively)7766
Preferred shares ($0.0001 par value; 10,000,000 preferred shares authorized; nil and nil preferred shares issued and outstanding, respectively)00
Additional paid-in capital6,030,7095,777,743
Accumulated other comprehensive loss(43,187)(46,610)
Accumulated Deficit(2,628,741)(2,415,507)
Total Tilray Brands, Inc. stockholders' equity3,358,8583,315,692
Non-controlling interests(15,817)14,251
Total stockholders' equity3,343,0413,329,943
Total liabilities and stockholders' equity$ 4,212,856$ 4,307,259
TLRY
Tilray Brands, Inc. engages in the research, cultivation, processing, and distribution of medical cannabis products in Canada, the United States, Europe, Australia, New Zealand, Latin America, and internationally. The company operates through four segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, and Wellness Business. It also offers medical and adult-use cannabis products; purchases and resells pharmaceutical and wellness products; and produces, markets, sells, and distributes beverage alcohol products, and hemp-based food and other wellness products. In addition, the company offers its products under the Tilray, Aphria, Broken Coast, Symbios, B!NGO, The Batch, Dubon, Good Supply, Solei, Chowie Wowie, Canaca, RIFF, SweetWater, Breckenridge Distillery, Alpine Beer Company, and Green Flash brands. It sells its products to retailers, wholesalers, patients, physicians, hospitals, pharmacies, researchers, and governments, as well as direct to consumers. The company was formerly known as Tilray, Inc. and changed its name to Tilray Brands, Inc. in January 2022. Tilray Brands, Inc. is headquartered in Leamington, Canada.
 CEO
 WEBSITEtilray.com
 INDUSTRYPharmaceuticals
 EMPLOYEES1600

Tilray Inc Frequently Asked Questions


What is the ticker symbol for Tilray Inc? What does TLRY stand for in stocks?

TLRY is the stock ticker symbol of Tilray Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Tilray Inc (TLRY)?

As of Fri Apr 19 2024, market cap of Tilray Inc is 1.34 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of TLRY stock?

You can check TLRY's fair value in chart for subscribers.

What is the fair value of TLRY stock?

You can check TLRY's fair value in chart for subscribers. The fair value of Tilray Inc is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Tilray Inc is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for TLRY so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Tilray Inc a good stock to buy?

The fair value guage provides a quick view whether TLRY is over valued or under valued. Whether Tilray Inc is cheap or expensive depends on the assumptions which impact Tilray Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for TLRY.

What is Tilray Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Fri Apr 19 2024, TLRY's PE ratio (Price to Earnings) is -3.8 and Price to Sales (PS) ratio is 1.8. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. TLRY PE ratio will change depending on the future growth rate expectations of investors.